Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
118 articles
(Page 2)
Gut Microbiome: A New Frontier in Predicting Immunotherapy Outcomes for Gynecologic Cancers
Study reveals gut bacteria's role in immunotherapy outcomes for cervical and endometrial cancer patients.
Immunotherapy Breakthrough: PD-1/PD-L1 Inhibitors Show Promise in Advanced Gastroesophageal Cancers
Meta-analysis reveals PD-1/PD-L1 inhibitors improve survival in advanced gastroesophageal cancers.
Subcutaneous Nivolumab: A Game-Changer for Advanced Kidney Cancer Treatment
Subcutaneous nivolumab proves noninferior to IV administration in advanced kidney cancer patients.
Cediranib/Olaparib Combo Falls Short in Platinum-Resistant Ovarian Cancer Trial
Phase II/III trial shows cediranib/olaparib not superior to chemotherapy in platinum-resistant ovarian cancer.
Pembrolizumab Boosts Disease-Free Survival in High-Risk Urothelial Carcinoma Post-Surgery
Adjuvant pembrolizumab improves disease-free survival in high-risk muscle-invasive urothelial carcinoma patients
Oral Roxadustat Shows Promise in Treating Chemotherapy-Induced Anemia
Study finds roxadustat noninferior to rHuEPO-α for chemotherapy-induced anemia in cancer patients.
Dual Checkpoint Inhibition Shows Promise in Molecularly Selected Prostate Cancer Patients
Phase II trial reveals promising results for dual immune checkpoint inhibition in specific mCRPC patients.
Immune Checkpoint Inhibitors in MS Patients: Low Relapse Risk, Promising Outlook
Study shows low relapse risk for MS patients on immune checkpoint inhibitors, suggesting safe use with precautions.
CheckMate 274: Nivolumab Boosts Survival in High-Risk Urothelial Cancer
Phase III trial shows adjuvant nivolumab improves disease-free survival in high-risk urothelial carcinoma.
T-DXd Shows Promising Results for HER2+ Breast Cancer with Brain Metastases
Large trial demonstrates T-DXd's efficacy in treating HER2+ breast cancer with brain metastases.
ADT and Heart Failure: New Study Reveals Increased Risk for Prostate Cancer Patients
Meta-analysis finds androgen deprivation therapy linked to higher heart failure risk in prostate cancer patients.
Antibiotics, PPIs, and Probiotics: No Impact on Immunotherapy Outcomes in ES-SCLC
Study finds common medications don't affect immunotherapy efficacy in extensive-stage small cell lung cancer.